Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

1,019 Results (Page 25 of 51)
- Relevance
  Sort by

Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

 Report
November 2025
187 Pages
Global

From

€4028EUR$4,500USD£3,519GBP

Global TROP2 Antibody Market Opportunity & Clinical Trials Insight 2030

 Report
February 2025
200 Pages
Global

From

€2506EUR$2,800USD£2,189GBP

CAR-T Cell Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
January 2024
174 Pages
Global

From

€3500EUR$4,189USD£3,164GBP

Cystic Fibrosis Therapeutics - Global Strategic Business Report

 Report
April 2026
282 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Acute Myeloid Leukemia - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2685EUR$3,000USD£2,346GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Leukemia Targeted Therapy Drugs Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Myelodysplastic Syndrome Drug Market - Global Forecast 2025-2030

 Report
August 2025
189 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Head and Neck Squamous Cell Carcinoma - Global Strategic Business Report

 Report
April 2026
917 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Esophageal Squamous Cell Carcinoma Market - Global Strategic Business Report

 Report
April 2026
275 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Breast Adenocarcinoma Treatment - Global Strategic Business Report

 Report
April 2026
294 Pages
Global

From

€5237EUR$5,850USD£4,574GBP

Therapeutics for Women's Health: Technologies and Global Markets

 Report
March 2025
159 Pages
Global

From

€4162EUR$4,650USD£3,636GBP

Alcohol Use Disorder - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1790EUR$2,000USD£1,564GBP

Multiple Myeloma Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4019EUR$4,490USD£3,511GBP

Myelodysplastic Syndrome - Pipeline Review, H1 2020

 Drug Pipelines
June 2020
1667 Pages
Global

From

€1790EUR$2,000USD£1,564GBP

Biotechnology in the US - Market Research Report 2015-2030

 Report
March 2025
51 Pages
United States

From

€1079EUR$1,205USD£942GBP

Halothane Market - Global Forecast to 2030

 Report
August 2025
183 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Autoimmune Collaboration and Licensing Deals 2016-2025

 Report
October 2025
500 Pages +
Global

From

€3576EUR$3,995USD£3,124GBP

Stem Cell Therapy Market - Global Forecast 2026-2032

 Report
January 2026
184 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Waldenstrom Macroglobulinemia - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1790EUR$2,000USD£1,564GBP

Precision and Personalized Medicine in Pharma - Thematic Intelligence

 Report
June 2023
62 Pages
Global

From

€1746EUR$1,950USD£1,525GBP

1,019 Results (Page 25 of 51)
- 1
- 23
- 24
- 25
- 26
- 27

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.